By Bridin Murnion

Conference Presentations

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT'

Nielsen S; Bruno R; Murnion B; Dunlop A; Degenhardt L; Demirkol A; Muhleisen P; Lintzeris N, 2014, 'TREATING CODEINE DEPENDENCE WITH BUPRENORPHINE: HOW MUCH IS ENOUGH?'

Nielsen S; Muhleisen P; Murnion B; Sadler C; Ling S; Smith C; Demirkol A; Dunlop AJ; Degenhardt L; Lintzeris N, 2013, 'PHARMACEUTICAL OPIOID TREATMENT PRESENTATIONS PRESCRIBED METHADONE OR BUPRENORPHINE IN THREE NEW SOUTH WALES LOCAL HEALTH DISTRICT DRUG TREATMENT SERVICES', Vol. 32, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400174&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Black E; Larance B; Mattick R; Lintzeris N; Degenhardt L; Bruno R; Nielsen S; Murnion B; Cohen M; Ali R; Dunlop A; Holland R, 2011, 'MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page